222 related articles for article (PubMed ID: 15623682)
1. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project.
Brown DL; Lisabeth LD; Garcia NM; Smith MA; Morgenstern LB
Neurology; 2004 Dec; 63(12):2250-4. PubMed ID: 15623682
[TBL] [Abstract][Full Text] [Related]
2. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of acute stroke and TIA diagnosis.
Morgenstern LB; Lisabeth LD; Mecozzi AC; Smith MA; Longwell PJ; McFarling DA; Risser JM
Neurology; 2004 Mar; 62(6):895-900. PubMed ID: 15037689
[TBL] [Abstract][Full Text] [Related]
4. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.
Morgenstern LB; Smith MA; Lisabeth LD; Risser JM; Uchino K; Garcia N; Longwell PJ; McFarling DA; Akuwumi O; Al-Wabil A; Al-Senani F; Brown DL; Moyé LA
Am J Epidemiol; 2004 Aug; 160(4):376-83. PubMed ID: 15286023
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with hospitalization for ischemic stroke and TIA following an emergency department headache visit.
Liberman AL; Lu J; Wang C; Cheng NT; Moncrieffe K; Lipton RB
Am J Emerg Med; 2021 Aug; 46():503-507. PubMed ID: 33191047
[TBL] [Abstract][Full Text] [Related]
6. Stroke risk after transient ischemic attack in a population-based setting.
Lisabeth LD; Ireland JK; Risser JM; Brown DL; Smith MA; Garcia NM; Morgenstern LB
Stroke; 2004 Aug; 35(8):1842-6. PubMed ID: 15192239
[TBL] [Abstract][Full Text] [Related]
7. Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project.
Domino JS; Baek J; Meurer WJ; Garcia N; Morgenstern LB; Campbell M; Lisabeth LD
Neurology; 2016 Nov; 87(21):2184-2191. PubMed ID: 27770075
[TBL] [Abstract][Full Text] [Related]
8. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
9. A population-based analysis of ethnic differences in admission to the intensive care unit after stroke.
Fletcher JJ; Morgenstern LB; Lisabeth LD; Sánchez BN; Skolarus LE; Smith MA; Garcia NM; Zahuranec DB
Neurocrit Care; 2012 Dec; 17(3):348-53. PubMed ID: 22892883
[TBL] [Abstract][Full Text] [Related]
10. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
Barber PA; Zhang J; Demchuk AM; Hill MD; Buchan AM
Neurology; 2001 Apr; 56(8):1015-20. PubMed ID: 11320171
[TBL] [Abstract][Full Text] [Related]
11. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal.
Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R
BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770
[TBL] [Abstract][Full Text] [Related]
12. Modelling care quality for patients after a transient ischaemic attack within the US Veterans Health Administration.
Arling G; Sico JJ; Reeves MJ; Myers L; Baye F; Bravata DM
BMJ Open Qual; 2019; 8(4):e000641. PubMed ID: 31909209
[TBL] [Abstract][Full Text] [Related]
13. A cohort study on physician documentation and the accuracy of administrative data coding to improve passive surveillance of transient ischaemic attacks.
Yu AYX; Quan H; McRae AD; Wagner GO; Hill MD; Coutts SB
BMJ Open; 2017 Jul; 7(6):e015234. PubMed ID: 28674141
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
[TBL] [Abstract][Full Text] [Related]
15. Ischemic stroke subtypes among Mexican Americans and non-Hispanic whites: the BASIC Project.
Uchino K; Risser JM; Smith MA; Moyé LA; Morgenstern LB
Neurology; 2004 Aug; 63(3):574-6. PubMed ID: 15304600
[TBL] [Abstract][Full Text] [Related]
16. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
Uchino K; Massaro L; Hammer MD
Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
[TBL] [Abstract][Full Text] [Related]
17. Determining intravenous rt-PA eligibility in the Emergency Department.
Mecozzi AC; Brown DL; Lisabeth LD; Barsan WG; Silbergleit R; Hickenbottom SL; Scott PA; Morgenstern LB
Neurocrit Care; 2007; 7(2):103-8. PubMed ID: 17763833
[TBL] [Abstract][Full Text] [Related]
18. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity.
Johnston SC; Fung LH; Gillum LA; Smith WS; Brass LM; Lichtman JH; Brown AN
Stroke; 2001 May; 32(5):1061-8. PubMed ID: 11340210
[TBL] [Abstract][Full Text] [Related]
19. Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy.
Poupore N; Strat D; Mackey T; Snell A; Nathaniel T
BMC Neurol; 2020 May; 20(1):197. PubMed ID: 32429850
[TBL] [Abstract][Full Text] [Related]
20. Urgent neurology consultation from the ED for transient ischemic attack.
Kim AS; Sidney S; Bernstein AL; Douglas VC; Johnston SC
Am J Emerg Med; 2011 Jul; 29(6):601-8. PubMed ID: 20825839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
